title: Bad news for neuroprotective therapies in PD?
authors.affiliation: Lund University, Basal ganglia pathophysiology unit, Lund, Sweden.
authors.forename: M Angela
authors.initials: MA
authors.lastname: Cenci
authors.forename: David J
authors.initials: DJ
authors.lastname: Brooks
mesh_terms: D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000473:pathology / Q000628:therapy*; D013378:Substantia Nigra / Q000473:pathology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D018696:Neuroprotective Agents; D014446:Tyrosine 3-Monooxygenase